Impact of Fenebrutinib Treatment on MRI Outcomes and Cerebrospinal Fluid Penetrance in Multiple Sclerosis: Results from the Phase II FENopta Study

Authors
Category Primary study
JournalNeurology
Year 2024
This article has no abstract
Epistemonikos ID: 13e7a351818dee1a4872bab20bcc864b1964bbfb
First added on: Feb 19, 2025